NeuroSense Files U.S. Patent for PrimeC TBI Treatment
NeuroSense filed a U.S. patent covering use of PrimeC’s components to treat traumatic brain injury and related CNS injuries. Protection could extend to 2047 if granted.
NeuroSense filed a U.S. patent covering use of PrimeC’s components to treat traumatic brain injury and related CNS injuries. Protection could extend to 2047 if granted.